Clearmind Medicine CMND
NASDAQ CMND
$5.99 -0.13 (-2.04%)
As of: Oct 21, 2026 · 3:52 PM EDT

Clearmind Medicine (CMND) Asset Utilization Ratio (2023 - 2026)

Updated

Clearmind Medicine's (CMND) Asset Utilization Ratio stood at 0.06 in FY2022 (year ended Oct 31, 2022).

Analysis

Clearmind Medicine (CMND) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Clearmind Medicine 9,526.05 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2026 0.13
Oct 31, 2025 0.42
Jul 31, 2025 0.17
Jan 31, 2025 0.16
Oct 31, 2024 -0.22
Jul 31, 2024 -0.23
Apr 30, 2024 -0.15
Oct 31, 2023 -0.34
API Access

Clearmind Medicine Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CMND&period=max&api_key=YOUR_API_KEY